| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $40.02K | $44.99K | $21.22K | $4.75K | $87.67M |
| R&D | – | – | – | – | – |
| SG&A | – | – | – | $4.75K | – |
| Operating Income | -$40.02K | -$44.99K | -$21.22K | -$4.75K | -$87.67M |
| Interest Expense | – | – | – | – | – |
| Tax Expense | – | – | – | – | – |
| Net Income | -$40.02K | -$44.99K | -$21.22K | -$4.75K | -$87.67M |
| EPS (basic) | 0.0000 | 0.0000 | 0.0000 | 0.0000 | -0.2400 |
| EPS (diluted) | 0.0000 | 0.0000 | 0.0000 | 0.0000 | -0.2400 |
| Shares (diluted) | – | – | – | – | – |